Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Centre for Brain and Cognitive Development and Department of Psychological Sciences, Birkbeck, University of London, London, UK.
Mol Autism. 2024 Oct 15;15(1):45. doi: 10.1186/s13229-024-00621-5.
Children with Neurofibromatosis 1 (NF1) show cognitive, behavioural and social differences compared to their peers. However, the age and sequence at which these differences begin to emerge is not fully understood. This prospective cohort study examines the cognitive, behavioural, ADHD trait and autism symptom development in infant and pre-school children with NF1 compared with typically developing (TD) children without a family history of neurodevelopmental conditions.
Data from standardised tests was gathered at 5, 10, 14, 24 and 36 months of age (NF1 n = 35, TD n = 29). Developmental trajectories of cognitive (Mullen Scales of Early Learning, MSEL) and adaptive behavioural (Vineland Adaptive Behavior Scales, VABS) development from 5 to 36 months were analysed using linear mixed modelling. Measures of ADHD (Child Behavior Checklist) and autism traits (ADOS-2, BOSA-MV and ADI-R) were assessed at 24 and 36 months.
The developmental trajectory of cognitive skills (all domains of the MSEL) and behavioural skills (four domains of the VABS) differed significantly between NF1 and TD groups. Post-hoc tests demonstrated that the NF1 participants scored significantly lower than TD participants at 24 months on all MSEL and VABS domains. The NF1 cohort demonstrated higher mean autism and ADHD traits at 24 months and 14% of the NF1 cohort met a research diagnostic classification for autism at 36 months.
The study has a relatively small sample size due to variable retention and rolling recruitment. Due to limitations imposed by the COVID-19 pandemic, we utilised the Brief Observation of Symptoms of Autism for Minimally Verbal children (BOSA-MV) for some participants, which was administered online and may not gather as accurate a picture of traits as ADOS-2. The BOSA-MV was utilised for 41% of participants with NF1 at 36 months compared to 11% at 24 months. This may explain the reduction in the percentage of children with NF1 that met autism criteria at 36 months.
By 24 months of age, the NF1 cohort show lower cognitive skills and adaptive behaviour and higher levels of autism and ADHD traits as compared to TD children. This has implications for developmental monitoring and referral for early interventions.
Not applicable.
与同龄人相比,患有神经纤维瘤病 1 型(NF1)的儿童在认知、行为和社会方面存在差异。然而,这些差异开始出现的年龄和顺序尚不完全清楚。本前瞻性队列研究比较了 NF1 婴儿和学龄前儿童与无神经发育病史的典型发育(TD)儿童的认知、行为、ADHD 特征和自闭症症状的发展。
在 5、10、14、24 和 36 个月时(NF1 n=35,TD n=29)收集标准化测试数据。使用线性混合模型分析从 5 到 36 个月的认知(Mullen 早期学习量表,MSEL)和适应性行为(Vineland 适应性行为量表,VABS)的发育轨迹。在 24 和 36 个月时评估 ADHD(儿童行为检查表)和自闭症特征(ADOS-2、BOSA-MV 和 ADI-R)。
NF1 和 TD 组之间认知技能(MSEL 的所有领域)和行为技能(VABS 的四个领域)的发育轨迹明显不同。事后检验表明,在所有 MSEL 和 VABS 领域,NF1 组参与者在 24 个月时的得分明显低于 TD 组。NF1 队列在 24 个月时表现出较高的平均自闭症和 ADHD 特征,在 36 个月时有 14%的 NF1 队列符合自闭症研究诊断分类。
由于保留和滚动招募的变化,该研究样本量相对较小。由于 COVID-19 大流行的限制,我们为一些参与者使用了最小语言的自闭症症状的简要观察(BOSA-MV),该测试是在线进行的,可能无法像 ADOS-2 一样准确地收集特征图片。在 36 个月时,NF1 组中有 41%的参与者使用了 BOSA-MV,而在 24 个月时只有 11%的参与者使用了 BOSA-MV。这可能解释了 36 个月时 NF1 儿童符合自闭症标准的百分比降低的原因。
在 24 个月时,NF1 队列的认知技能和适应性行为较低,自闭症和 ADHD 特征水平较高,与 TD 儿童相比。这对发育监测和早期干预的转介有影响。
不适用。